Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization: an In-vitro Analysis of Oxytocin Receptor Expression and Signaling
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- Pregnancy · Phase NA · Jun 2020
- Labor Pain · Phase NA · Aug 2016
- Pain · Phase NA · Dec 2014
- Infertility · Phase NA · Jan 2014
- Pain · Phase NA · Jan 2014
See all terminations from Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Listed as NCT02762669, this NA trial focuses on Postpartum Hemorrhage and remains terminated or withdrawn. Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital, it has been updated 10 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Nov 2022 — Jul 2024 [monthly]
Recruiting NA
-
Dec 2021 — Nov 2022 [monthly]
Recruiting NA
-
Jan 2021 — Dec 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2019 — Oct 2020 [monthly]
Recruiting NA
-
Sep 2018 — Mar 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital
For direct contact, visit the study record on ClinicalTrials.gov .